LT2007416T - Paratiroidinis hormonas (pth), skirtas naudoti išemijos gydymui - Google Patents
Paratiroidinis hormonas (pth), skirtas naudoti išemijos gydymuiInfo
- Publication number
- LT2007416T LT2007416T LTEP07724213.9T LT07724213T LT2007416T LT 2007416 T LT2007416 T LT 2007416T LT 07724213 T LT07724213 T LT 07724213T LT 2007416 T LT2007416 T LT 2007416T
- Authority
- LT
- Lithuania
- Prior art keywords
- pth
- ischemia
- treatment
- paratyroid
- hormone
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 208000028867 ischemia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79294306P | 2006-04-19 | 2006-04-19 | |
PCT/EP2007/003272 WO2007118680A2 (en) | 2006-04-19 | 2007-04-12 | Remedies for ischemia |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2007416T true LT2007416T (lt) | 2018-02-12 |
Family
ID=38609853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP07724213.9T LT2007416T (lt) | 2006-04-19 | 2007-04-12 | Paratiroidinis hormonas (pth), skirtas naudoti išemijos gydymui |
Country Status (11)
Country | Link |
---|---|
US (1) | US8207116B2 (lt) |
EP (1) | EP2007416B1 (lt) |
CY (1) | CY1119819T1 (lt) |
DK (1) | DK2007416T3 (lt) |
ES (1) | ES2654251T3 (lt) |
HU (1) | HUE035446T2 (lt) |
LT (1) | LT2007416T (lt) |
PL (1) | PL2007416T3 (lt) |
PT (1) | PT2007416T (lt) |
SI (1) | SI2007416T1 (lt) |
WO (1) | WO2007118680A2 (lt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2138572A1 (en) * | 2008-06-26 | 2009-12-30 | t2cure GmbH | Mesoangioblast-like cell as well as methods and uses relating thereto |
WO2010045229A2 (en) | 2008-10-13 | 2010-04-22 | University Of Rochester | Protecting and repairing cartilage and musculoskeletal soft tissues |
GB201619861D0 (en) * | 2016-11-24 | 2017-01-11 | Narodden Salomon | Treatments for heart failure and cardiac ischaemic reperfusion injury |
US20210380937A1 (en) * | 2017-04-04 | 2021-12-09 | The Board Of Trustees Of The Leland Stanford Junior University | Preparation , expansion, and uses of adult pluripotent stem cells |
JP7329265B2 (ja) | 2018-09-21 | 2023-08-18 | アプステム セラピューティクス、インコーポレイテッド | ヒト多能性成人幹細胞 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030181373A1 (en) * | 2000-08-11 | 2003-09-25 | Toshio Ohhashi | Vascular relaxation agents |
US20040161412A1 (en) | 2002-08-22 | 2004-08-19 | The Cleveland Clinic Foundation | Cell-based VEGF delivery |
US7384786B2 (en) * | 2003-07-16 | 2008-06-10 | Scimed Life Systems, Inc. | Aligned scaffolds for improved myocardial regeneration |
EP1527785A1 (en) | 2003-10-27 | 2005-05-04 | Ludwig-Maximilians-Universität München | Use of G-CSF for treating ischemia |
KR20170005163A (ko) * | 2003-11-17 | 2017-01-11 | 노파르티스 아게 | 디펩티딜 펩티다제 ⅳ 억제제의 용도 |
US20070021336A1 (en) * | 2004-12-24 | 2007-01-25 | Christen Anderson | Use of GLP-1 and agonists thereof to prevent cardiac myocyte apoptosis |
US7393827B2 (en) * | 2004-12-30 | 2008-07-01 | Diakine Therapeutics, Inc. | Pharmaceutical compositions and methods for restoring β-cell mass and function |
-
2007
- 2007-04-12 PL PL07724213T patent/PL2007416T3/pl unknown
- 2007-04-12 EP EP07724213.9A patent/EP2007416B1/en active Active
- 2007-04-12 ES ES07724213.9T patent/ES2654251T3/es active Active
- 2007-04-12 WO PCT/EP2007/003272 patent/WO2007118680A2/en active Application Filing
- 2007-04-12 DK DK07724213.9T patent/DK2007416T3/en active
- 2007-04-12 PT PT77242139T patent/PT2007416T/pt unknown
- 2007-04-12 HU HUE07724213A patent/HUE035446T2/en unknown
- 2007-04-12 LT LTEP07724213.9T patent/LT2007416T/lt unknown
- 2007-04-12 SI SI200731997T patent/SI2007416T1/en unknown
- 2007-04-12 US US12/296,584 patent/US8207116B2/en not_active Expired - Fee Related
-
2017
- 2017-12-20 CY CY20171101335T patent/CY1119819T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007118680A2 (en) | 2007-10-25 |
ES2654251T3 (es) | 2018-02-12 |
SI2007416T1 (en) | 2018-02-28 |
PT2007416T (pt) | 2018-01-03 |
US8207116B2 (en) | 2012-06-26 |
US20090286730A1 (en) | 2009-11-19 |
DK2007416T3 (en) | 2017-12-11 |
PL2007416T3 (pl) | 2018-05-30 |
HUE035446T2 (en) | 2018-05-02 |
CY1119819T1 (el) | 2018-06-27 |
EP2007416A2 (en) | 2008-12-31 |
WO2007118680A3 (en) | 2008-02-14 |
EP2007416B1 (en) | 2017-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2434604B (en) | Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same | |
IL249838A0 (en) | Telomerase activator compounds for use in the treatment of diseases related thereto | |
ZA200900305B (en) | Dressing | |
GB0606604D0 (en) | Treatment apparatus | |
GB0624874D0 (en) | Treatment | |
HUE037109T2 (hu) | Endoxifén rák kezelésében történõ alkalmazásra | |
SI1978947T1 (sl) | Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij | |
IL194202A0 (en) | Treatment using citrulline | |
GB0610553D0 (en) | Dressing | |
EP2023950A4 (en) | CANCER TREATMENT WITH URODILATIN | |
PL1945243T3 (pl) | Zastosowanie kalcytoniny w leczeniu rzs | |
TWI367274B (en) | Composition for fabric treatment | |
LT2007416T (lt) | Paratiroidinis hormonas (pth), skirtas naudoti išemijos gydymui | |
HK1151971A1 (en) | Compounds for use in the treatment of cancer | |
PT1984005E (pt) | Uso de complexos de gálio para o tratamento de melanomas | |
GB0606921D0 (en) | Skin dressing | |
ZA200904478B (en) | Novel therapeutic use for treating leukaemia | |
GB0604460D0 (en) | Treatment | |
IL193414A0 (en) | Meridamycin analogues for the treatment ofneurodegenererative disorders | |
EP2056811A4 (en) | MODAFINIL TREATMENT AGAINST EARLY EJACULATION | |
ZA200807156B (en) | Liquid treatment composition | |
GB0622920D0 (en) | Topical treatment | |
GB0602857D0 (en) | The treatment of sialorrhoea | |
GB0614970D0 (en) | Compounds For Use In Therapy | |
GB0610431D0 (en) | Treatment |